What’s the Deal with Domperidone?

have failed to improve milk supply.

Clinical studies have demonstrated the effectiveness of domperidone in increasing milk production. It has been shown to enhance prolactin levels and significantly improve milk supply in lactating mothers. However, the exact mechanisms by which domperidone stimulates milk production are not fully understood. It is believed to work by increasing the release of prolactin from the pituitary gland and by stimulating the suckling reflex in infants.

When prescribed for lactation support, domperidone is typically taken orally as tablets or suspension. The dosage and duration of treatment vary depending on individual needs, and it is important to follow the healthcare provider's instructions. Domperidone is usually started at a low dose (1x 10mg tablet) and gradually increased as necessary, commonly to 30mg (3x 10mg tablets) per day. The treatment duration may vary, but it is often recommended to continue the medication until the desired milk supply is achieved, and then it can be gradually tapered off. It is important to note that domperidone should only be used under medical supervision, as it is associated with certain risks and side effects. The most common side effects include headache, dizziness, dry mouth, and gastrointestinal disturbances such as diarrhea or constipation. In rare cases, it may cause serious cardiac arrhythmias, especially in individuals with underlying heart conditions or those taking other medications that can interact with domperidone. Therefore, it is important to discuss any existing medical conditions or medications with a healthcare professional before starting domperidone.

Before using a thickener in breast milk, it is important to consult with a lactation or healthcare provider to determine the appropriate type and amount of thickener to use. Over-thickening breast milk can increase the risk of dehydration or constipation, and under-thickening breast milk may not provide enough support for swallowing difficulties.

The Advisor Innovation Summit is back in 2023 with a focus on how advisers can adapt to transform and thrive in the future.

As the advice industry copes with economic uncertainty and generational shifts in wealth management, the highlyanticipated Adviser Innovation Summit is returning this year to arm advisers with the strategies they need to flourish in an ever-changing landscape.

Taking place over two days — 8 and 15 June 2023 — the summit will unpack how advice practices could revamp their business models to succeed even when the market is volatile and deliver cost-effective advice, boost efficiencies, and meet compliance requirements. The IPA conference, also over two days, will provide delegates with key